English

PetLife Pharmaceuticals, Inc.

EDGAR

PTLF Quarterly report (10-Q) · filed 2018-07-17

61 filing records in this dataset, filed from 2007-04-16 to 2018-07-17. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2008-05-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Cash and cash equivalents: 7.86 thousand USD 2018-02-28 Source
Exact value

7856 USD
Long-term debt including current maturities: Not available
Shares outstanding: 80.3 million shares 2018-02-28 Source
Exact value

80256702 shares

Reported share-count change

28.81% · 18 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

62303909 shares · 2017-02-28· Source
80256702 shares · 2018-02-28· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-3.71 million USD

2017-03-01 – 2018-02-28

Exact inputs and evidence

Net income: -815017 USD · 2017-03-01 – 2017-05-31 Source
Net income: -23256850 USD · 2016-09-01 – 2017-08-31 Source
Net income: -21257431 USD · 2016-09-01 – 2017-05-31 Source
Net income: -466660 USD · 2017-09-01 – 2017-11-30 Source
Net income: -427064 USD · 2017-12-01 – 2018-02-28 Source

Operating cash flow

-262 thousand USD

2017-03-01 – 2018-02-28

Exact inputs and evidence

Operating cash flow: -433198 USD · 2016-09-01 – 2017-05-31 Source
Operating cash flow: -339409 USD · 2016-09-01 – 2017-02-28 Source
Operating cash flow: -318918 USD · 2016-09-01 – 2017-08-31 Source
Operating cash flow: -433198 USD · 2016-09-01 – 2017-05-31 Source
Operating cash flow: -119942 USD · 2017-09-01 – 2017-11-30 Source
Operating cash flow: -282396 USD · 2017-09-01 – 2018-02-28 Source
Operating cash flow: -119942 USD · 2017-09-01 – 2017-11-30 Source

Capital expenditure

37 thousand USD

2011-09-01 – 2012-08-31

Exact inputs and evidence

Capital expenditure: 36130 USD · 2011-09-01 – 2011-11-30 Source
Capital expenditure: 36971 USD · 2011-09-01 – 2012-02-28 Source
Capital expenditure: 36130 USD · 2011-09-01 – 2011-11-30 Source
Capital expenditure: 36971 USD · 2011-09-01 – 2012-05-31 Source
Capital expenditure: 36971 USD · 2011-09-01 – 2012-02-28 Source
Capital expenditure: 36971 USD · 2011-09-01 – 2012-08-31 Source
Capital expenditure: 36971 USD · 2011-09-01 – 2012-05-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2018-07-17.

Financial data available through: 2017-08-31.

Coverage by financial measure

Revenue: 1 of 11 periods available· newest 2014-08-31
Operating income: 6 of 11 periods available· newest 2017-08-31
Net income: 10 of 11 periods available· newest 2017-08-31
Operating cash flow: 10 of 11 periods available· newest 2017-08-31
Capital expenditure: 1 of 11 periods available· newest 2012-08-31
Total assets: 10 of 11 periods available· newest 2017-08-31
Total liabilities: 9 of 11 periods available· newest 2017-08-31
Current assets: 8 of 11 periods available· newest 2017-08-31
Current liabilities: 8 of 11 periods available· newest 2017-08-31
Cash and cash equivalents: 8 of 11 periods available· newest 2017-08-31
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2017-08-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 19.57 million

Prior period

−USD 3.69 million

2015-09-01 – 2016-08-31
Current period

−USD 23.26 million

2016-09-01 – 2017-08-31

Exact inputs and evidence

-23256850 − -3687040 = -19569810 USD

-3687040 USD · 2015-09-01 – 2016-08-31
Inspect prior input Prior source
-23256850 USD · 2016-09-01 – 2017-08-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · PetLife Pharmaceuticals, Inc. · 2017-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Year-over-year change in Net income: -19569810 USD Concept: fundies:NetIncome Period: 2016-09-01 to 2017-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -23256850 USD (2016-09-01 to 2017-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000149315217014624/ptlf-20170831.xml#81782 Filing: 000149315217014624 Input fundies:NetIncome: -3687040 USD (2015-09-01 to 2016-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000149315217014624/ptlf-20170831.xml#81910 Filing: 000149315217014624
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 167,079

Prior period

−USD 151,839

2015-09-01 – 2016-08-31
Current period

−USD 318,918

2016-09-01 – 2017-08-31

Exact inputs and evidence

-318918 − -151839 = -167079 USD

-151839 USD · 2015-09-01 – 2016-08-31
Inspect prior input Prior source
-318918 USD · 2016-09-01 – 2017-08-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · PetLife Pharmaceuticals, Inc. · 2017-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Year-over-year change in Operating cash flow: -167079 USD Concept: fundies:OperatingCashFlow Period: 2016-09-01 to 2017-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -318918 USD (2016-09-01 to 2017-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000149315217014624/ptlf-20170831.xml#291926 Filing: 000149315217014624 Input fundies:OperatingCashFlow: -151839 USD (2015-09-01 to 2016-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000149315217014624/ptlf-20170831.xml#292110 Filing: 000149315217014624
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2014 2013-09-01 – 2014-08-31

Revenue USD 0
Operating costs Derived USD 1.51 million
Operating income −USD 1.51 million
Tax, interest and other Derived USD 0
Net income −USD 1.51 million

Cash

Operating cash flow −USD 267,066
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2014 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2014 2013-09-01 – 2014-08-31	0	1512051 Derived	-1512051	0 Derived	-1512051	Unavailable	Source 2013-09-01 – 2014-08-31: 0 USD Inspect Revenue Open source 2013-09-01 – 2014-08-31: -1512051 USD Inspect Operating Income Open source 2013-09-01 – 2014-08-31: -1512051 USD Inspect Net Income Open source 2013-09-01 – 2014-08-31: -267066 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 0 2014

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-08-31	Revenue	0	Revenue: 0 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20142014-08-31	Year over year	No prior comparable period	Revenue: 0 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20142014-08-31	Operating margin	Not reported	Operating Income: -1512051 Open source Revenue: 0 Open source
20142014-08-31	Net margin	Not reported	Net Income: -1512051 Open source Revenue: 0 Open source
20142014-08-31	Free cash flow margin	Not reported	Revenue: 0 Open source Operating Cash Flow: -267066 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -267.1K 2014

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-08-31	Operating cash flow	-267066	Operating Cash Flow: -267066 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-08-31	Free cash flow	Unavailable	Operating Cash Flow: -267066 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

0% 2014

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20142014-08-31	Liabilities / assets	0%	Total Liabilities: 0 Open source Total Assets: 17434 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20142014-08-31	Current assets / current liabilities	Not reported	Current Assets: 17434 Open source Current Liabilities: 0 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2007 2006-09-01 – 2007-08-31	−USD 249,498 Exact value Exact value: -249498 USD 2006-09-01 – 2007-08-31: -249498 USD Inspect Net Income Open source Share or cite Citation for Net Income · PetLife Pharmaceuticals, Inc. · 2007-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Net Income: -249498 USD Concept: fundies:NetIncome Period: 2006-09-01 to 2007-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3ANetIncome&period=2007-08-31&surface=latest&period_type=duration&start=2006-09-01&unit=USD&dimensions= Input fundies:NetIncome: -249498 USD (2006-09-01 to 2007-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/0001137091-08-000724.txt#4092 The citation records this snapshot. The page link may show a newer release later.	−USD 274,034 Exact value Exact value: -274034 USD 2006-09-01 – 2007-08-31: -274034 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PetLife Pharmaceuticals, Inc. · 2007-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Operating Cash Flow: -274034 USD Concept: fundies:OperatingCashFlow Period: 2006-09-01 to 2007-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3AOperatingCashFlow&period=2007-08-31&surface=latest&period_type=duration&start=2006-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -274034 USD (2006-09-01 to 2007-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/0001137091-08-000724.txt#4234 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2008 2007-09-01 – 2008-08-31	−USD 284,267 Exact value Exact value: -284267 USD 2007-09-01 – 2008-08-31: -284267 USD Inspect Net Income Open source Share or cite Citation for Net Income · PetLife Pharmaceuticals, Inc. · 2008-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Net Income: -284267 USD Concept: fundies:NetIncome Period: 2007-09-01 to 2008-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3ANetIncome&period=2008-08-31&surface=latest&period_type=duration&start=2007-09-01&unit=USD&dimensions= Input fundies:NetIncome: -284267 USD (2007-09-01 to 2008-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/0001393905-10-000239.txt#2899 The citation records this snapshot. The page link may show a newer release later.	−USD 252,908 Exact value Exact value: -252908 USD 2007-09-01 – 2008-08-31: -252908 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PetLife Pharmaceuticals, Inc. · 2008-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Operating Cash Flow: -252908 USD Concept: fundies:OperatingCashFlow Period: 2007-09-01 to 2008-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3AOperatingCashFlow&period=2008-08-31&surface=latest&period_type=duration&start=2007-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -252908 USD (2007-09-01 to 2008-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/0001393905-10-000239.txt#3055 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2009 2008-09-01 – 2009-08-31	−USD 232,867 Exact value Exact value: -232867 USD 2008-09-01 – 2009-08-31: -232867 USD Inspect Net Income Open source Share or cite Citation for Net Income · PetLife Pharmaceuticals, Inc. · 2009-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Net Income: -232867 USD Concept: fundies:NetIncome Period: 2008-09-01 to 2009-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3ANetIncome&period=2009-08-31&surface=latest&period_type=duration&start=2008-09-01&unit=USD&dimensions= Input fundies:NetIncome: -232867 USD (2008-09-01 to 2009-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/0001393905-10-000709.txt#3804 The citation records this snapshot. The page link may show a newer release later.	−USD 299,588 Exact value Exact value: -299588 USD 2008-09-01 – 2009-08-31: -299588 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PetLife Pharmaceuticals, Inc. · 2009-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Operating Cash Flow: -299588 USD Concept: fundies:OperatingCashFlow Period: 2008-09-01 to 2009-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3AOperatingCashFlow&period=2009-08-31&surface=latest&period_type=duration&start=2008-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -299588 USD (2008-09-01 to 2009-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/0001393905-10-000709.txt#3946 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2010 2009-09-01 – 2010-08-31	−USD 118,405 Exact value Exact value: -118405 USD 2009-09-01 – 2010-08-31: -118405 USD Inspect Net Income Open source Share or cite Citation for Net Income · PetLife Pharmaceuticals, Inc. · 2010-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Net Income: -118405 USD Concept: fundies:NetIncome Period: 2009-09-01 to 2010-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3ANetIncome&period=2010-08-31&surface=latest&period_type=duration&start=2009-09-01&unit=USD&dimensions= Input fundies:NetIncome: -118405 USD (2009-09-01 to 2010-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/0001393905-10-000709.txt#3804 The citation records this snapshot. The page link may show a newer release later.	−USD 31,865 Exact value Exact value: -31865 USD 2009-09-01 – 2010-08-31: -31865 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PetLife Pharmaceuticals, Inc. · 2010-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Operating Cash Flow: -31865 USD Concept: fundies:OperatingCashFlow Period: 2009-09-01 to 2010-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3AOperatingCashFlow&period=2010-08-31&surface=latest&period_type=duration&start=2009-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -31865 USD (2009-09-01 to 2010-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/0001393905-10-000709.txt#3946 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2012 2011-09-01 – 2012-08-31	−USD 3.26 million Exact value Exact value: -3260801 USD 2011-09-01 – 2012-08-31: -3260801 USD Inspect Net Income Open source Share or cite Citation for Net Income · PetLife Pharmaceuticals, Inc. · 2012-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Net Income: -3260801 USD Concept: fundies:NetIncome Period: 2011-09-01 to 2012-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3ANetIncome&period=2012-08-31&surface=latest&period_type=duration&start=2011-09-01&unit=USD&dimensions= Input fundies:NetIncome: -3260801 USD (2011-09-01 to 2012-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000107997414000556/evgi-20130831.xml#286811 Filing: 000107997414000556 The citation records this snapshot. The page link may show a newer release later.	−USD 400,119 Exact value Exact value: -400119 USD 2011-09-01 – 2012-08-31: -400119 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PetLife Pharmaceuticals, Inc. · 2012-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Operating Cash Flow: -400119 USD Concept: fundies:OperatingCashFlow Period: 2011-09-01 to 2012-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3AOperatingCashFlow&period=2012-08-31&surface=latest&period_type=duration&start=2011-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -400119 USD (2011-09-01 to 2012-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000107997414000556/evgi-20130831.xml#289241 Filing: 000107997414000556 The citation records this snapshot. The page link may show a newer release later.	USD 36,971 Exact value Exact value: 36971 USD 2011-09-01 – 2012-08-31: 36971 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · PetLife Pharmaceuticals, Inc. · 2012-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Capital Expenditure: 36971 USD Concept: fundies:CapitalExpenditure Period: 2011-09-01 to 2012-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3ACapitalExpenditure&period=2012-08-31&surface=latest&period_type=duration&start=2011-09-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 36971 USD (2011-09-01 to 2012-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000107997414000556/evgi-20130831.xml#289737 Filing: 000107997414000556 The citation records this snapshot. The page link may show a newer release later.	−USD 437,090 Calculation and evidence -400119 − 36971 USD Exact free cash flow: -437090 USD 2011-09-01 – 2012-08-31: -400119 USD · Inspect Operating Cash Flow · Source 2011-09-01 – 2012-08-31: 36971 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · PetLife Pharmaceuticals, Inc. · 2012-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Free cash flow: -437090 USD Concept: free-cash-flow Period: 2011-09-01 to 2012-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -400119 USD (2011-09-01 to 2012-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000107997414000556/evgi-20130831.xml#289241 Filing: 000107997414000556 Input fundies:CapitalExpenditure: 36971 USD (2011-09-01 to 2012-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000107997414000556/evgi-20130831.xml#289737 Filing: 000107997414000556 The citation records this snapshot. The page link may show a newer release later.
2013 2012-09-01 – 2013-08-31	−USD 1.62 million Exact value Exact value: -1622269 USD 2012-09-01 – 2013-08-31: -1622269 USD Inspect Net Income Open source Share or cite Citation for Net Income · PetLife Pharmaceuticals, Inc. · 2013-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Net Income: -1622269 USD Concept: fundies:NetIncome Period: 2012-09-01 to 2013-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3ANetIncome&period=2013-08-31&surface=latest&period_type=duration&start=2012-09-01&unit=USD&dimensions= Input fundies:NetIncome: -1622269 USD (2012-09-01 to 2013-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000107997414000556/evgi-20130831.xml#286684 Filing: 000107997414000556 The citation records this snapshot. The page link may show a newer release later.	−USD 137,097 Exact value Exact value: -137097 USD 2012-09-01 – 2013-08-31: -137097 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PetLife Pharmaceuticals, Inc. · 2013-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Operating Cash Flow: -137097 USD Concept: fundies:OperatingCashFlow Period: 2012-09-01 to 2013-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3AOperatingCashFlow&period=2013-08-31&surface=latest&period_type=duration&start=2012-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -137097 USD (2012-09-01 to 2013-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000107997414000556/evgi-20130831.xml#289057 Filing: 000107997414000556 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2014 2013-09-01 – 2014-08-31	−USD 1.51 million Exact value Exact value: -1512051 USD 2013-09-01 – 2014-08-31: -1512051 USD Inspect Net Income Open source Share or cite Citation for Net Income · PetLife Pharmaceuticals, Inc. · 2014-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Net Income: -1512051 USD Concept: fundies:NetIncome Period: 2013-09-01 to 2014-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3ANetIncome&period=2014-08-31&surface=latest&period_type=duration&start=2013-09-01&unit=USD&dimensions= Input fundies:NetIncome: -1512051 USD (2013-09-01 to 2014-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000149315216006631/ptlf-20150831.xml#83445 Filing: 000149315216006631 The citation records this snapshot. The page link may show a newer release later.	−USD 267,066 Exact value Exact value: -267066 USD 2013-09-01 – 2014-08-31: -267066 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PetLife Pharmaceuticals, Inc. · 2014-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Operating Cash Flow: -267066 USD Concept: fundies:OperatingCashFlow Period: 2013-09-01 to 2014-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3AOperatingCashFlow&period=2014-08-31&surface=latest&period_type=duration&start=2013-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -267066 USD (2013-09-01 to 2014-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000149315216006631/ptlf-20150831.xml#82079 Filing: 000149315216006631 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2015 2014-09-01 – 2015-08-31	−USD 1.93 million Exact value Exact value: -1932201 USD 2014-09-01 – 2015-08-31: -1932201 USD Inspect Net Income Open source Share or cite Citation for Net Income · PetLife Pharmaceuticals, Inc. · 2015-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Net Income: -1932201 USD Concept: fundies:NetIncome Period: 2014-09-01 to 2015-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3ANetIncome&period=2015-08-31&surface=latest&period_type=duration&start=2014-09-01&unit=USD&dimensions= Input fundies:NetIncome: -1932201 USD (2014-09-01 to 2015-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000149315216016114/ptlf-20160831.xml#54044 Filing: 000149315216016114 The citation records this snapshot. The page link may show a newer release later.	−USD 22,034 Exact value Exact value: -22034 USD 2014-09-01 – 2015-08-31: -22034 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PetLife Pharmaceuticals, Inc. · 2015-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Operating Cash Flow: -22034 USD Concept: fundies:OperatingCashFlow Period: 2014-09-01 to 2015-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3AOperatingCashFlow&period=2015-08-31&surface=latest&period_type=duration&start=2014-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -22034 USD (2014-09-01 to 2015-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000149315216016114/ptlf-20160831.xml#44283 Filing: 000149315216016114 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2016 2015-09-01 – 2016-08-31	−USD 3.69 million Exact value Exact value: -3687040 USD 2015-09-01 – 2016-08-31: -3687040 USD Inspect Net Income Open source Share or cite Citation for Net Income · PetLife Pharmaceuticals, Inc. · 2016-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Net Income: -3687040 USD Concept: fundies:NetIncome Period: 2015-09-01 to 2016-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3ANetIncome&period=2016-08-31&surface=latest&period_type=duration&start=2015-09-01&unit=USD&dimensions= Input fundies:NetIncome: -3687040 USD (2015-09-01 to 2016-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000149315217014624/ptlf-20170831.xml#81910 Filing: 000149315217014624 The citation records this snapshot. The page link may show a newer release later.	−USD 151,839 Exact value Exact value: -151839 USD 2015-09-01 – 2016-08-31: -151839 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PetLife Pharmaceuticals, Inc. · 2016-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Operating Cash Flow: -151839 USD Concept: fundies:OperatingCashFlow Period: 2015-09-01 to 2016-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3AOperatingCashFlow&period=2016-08-31&surface=latest&period_type=duration&start=2015-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -151839 USD (2015-09-01 to 2016-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000149315217014624/ptlf-20170831.xml#292110 Filing: 000149315217014624 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2016-09-01 – 2017-08-31	−USD 23.26 million Exact value Exact value: -23256850 USD 2016-09-01 – 2017-08-31: -23256850 USD Inspect Net Income Open source Share or cite Citation for Net Income · PetLife Pharmaceuticals, Inc. · 2017-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Net Income: -23256850 USD Concept: fundies:NetIncome Period: 2016-09-01 to 2017-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3ANetIncome&period=2017-08-31&surface=latest&period_type=duration&start=2016-09-01&unit=USD&dimensions= Input fundies:NetIncome: -23256850 USD (2016-09-01 to 2017-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000149315217014624/ptlf-20170831.xml#81782 Filing: 000149315217014624 The citation records this snapshot. The page link may show a newer release later.	−USD 318,918 Exact value Exact value: -318918 USD 2016-09-01 – 2017-08-31: -318918 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · PetLife Pharmaceuticals, Inc. · 2017-08-31 PetLife Pharmaceuticals, Inc. (edgar:1354591) Operating Cash Flow: -318918 USD Concept: fundies:OperatingCashFlow Period: 2016-09-01 to 2017-08-31 Values: Latest reported Published: 2026-11-02T22:04:43Z Snapshot: 2236681e9c50f3adf9a20eaf63690f19b84802a2e74400de80912036a8fadde6 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1354591/explain?concept=fundies%3AOperatingCashFlow&period=2017-08-31&surface=latest&period_type=duration&start=2016-09-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -318918 USD (2016-09-01 to 2017-08-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1354591/000149315217014624/ptlf-20170831.xml#291926 Filing: 000149315217014624 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

61 filings · 924 latest values · 929 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001354591, 1354591, PTLF, edgar:1354591

Also known as AZTEK VENTURES INC., ECO VENTURES GROUP, INC., GENESIS URANIUM CORP., Modern Renewable Technologies, Inc., PetLife Pharmaceuticals, Inc., Vault Technology, Inc.

PetLife Pharmaceuticals, Inc.

Latest quarter

Revenue

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2014 2013-09-01 – 2014-08-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation